Mesothelioma Avastin Plus Pemetrexed-cisplatin Study

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2008
Our hypothesis is that the addition of bevacizumab to the standard chemotherapy treatment of MPM will improve overall survival and quality of life beyond that achieved with chemotherapy alone.
Epistemonikos ID: ea8704978f703e734700947b14c779482ce137a8
First added on: May 04, 2024